Psychedelics Investors wince as FDA panel rejects proposal to approve ‘molly’ for PTSD therapy Despite rejection from the advisory committee, the FDA won't make its final decision on the matter until August Rowan DunneJune 5, 2024
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
Psychedelics Beckley Waves establishes ethics council for the psychedelics sector Beckley Waves was created by the Beckley Foundation's Founder Amanda Feilding Rowan DunneJune 1, 2023
News MAPS launches online education program on psychedelics The new school aims to provide education on psychedelic medicines to promote safe, legal and equitable access Natalia Buendia CalvilloMay 3, 2023
Psychedelics Psyched Wellness formulates first commercial Amanita muscaria extract The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees Rowan DunneFebruary 9, 2023
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Analysis What happened to Canada’s ibogaine clinics? Following a surge of interest, ibogaine therapy in the country disappeared. But recent signs show regulators are warming to the promising plant Suzannah WeissDecember 23, 2020
Health and Safety Could microdosing psychedelics help treat schizophrenia? Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can Michelle GamageSeptember 23, 2020